Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positron Emission Tomography-based Response Assessment in Isocitrate Dehydrogenase (IDH)-Mutant Gliomas - a Bicentric, Prospective, Observational Study

NCT07159607 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT07159607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07159607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positron Emission Tomography-based Response Assessment in Isocitrate Dehydrogenase (IDH)-Mutant Gliomas - a Bicentric, Prospective, Observational Study
Lead sponsor
LMU Klinikum
Phase
Observational
Overall status
Recruiting
Start date
July 17, 2025
Completion date
July 16, 2030
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

idh-mutant glioma (oligodendroglioma, astrocytoma)